Matches in Nanopublications for { ?s ?p "[However, independent of the presence of DR4 and DR5, TRAIL cytotoxicity assays revealed that pancreatic cancer cells showed a significantly lower sensitivity (LD(50)>85 ng/ml) to TRAIL treatment than Jurkat T lymphoma cells (LD(50)=7.2 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP803936.RAU0JoIBBs_reMiOwlfgBSKfEjrzOLjtmUcHSixTHIS24130_assertion description "[However, independent of the presence of DR4 and DR5, TRAIL cytotoxicity assays revealed that pancreatic cancer cells showed a significantly lower sensitivity (LD(50)>85 ng/ml) to TRAIL treatment than Jurkat T lymphoma cells (LD(50)=7.2 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803936.RAU0JoIBBs_reMiOwlfgBSKfEjrzOLjtmUcHSixTHIS24130_provenance.
- assertion description "[However, independent of the presence of DR4 and DR5, TRAIL cytotoxicity assays revealed that pancreatic cancer cells showed a significantly lower sensitivity (LD(50)>85 ng/ml) to TRAIL treatment than Jurkat T lymphoma cells (LD(50)=7.2 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP306088.RA4ji8-QW2Za-8rVV-0Vd6Dy7ilbLxI51pETcNtelcKQw130_assertion description "[However, independent of the presence of DR4 and DR5, TRAIL cytotoxicity assays revealed that pancreatic cancer cells showed a significantly lower sensitivity (LD(50)>85 ng/ml) to TRAIL treatment than Jurkat T lymphoma cells (LD(50)=7.2 ng/ml).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306088.RA4ji8-QW2Za-8rVV-0Vd6Dy7ilbLxI51pETcNtelcKQw130_provenance.